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Dementia, a devastating, progressive disease, is typically assessed using a combination of 
cognitive testing, physical examination and physical tasks that test the patient’s ability to 
engage in instrumental activities of daily living (IADL). These tests are designed to 
evaluate skills such as memory, general motor skills, gaze etc. that enable us to function. 
Clinical settings have limited access to space and tools that can be used to design said 
tests. Virtual reality is a cost-effective alternative that can be utilized in such settings to 
diagnose MCI and dementia. Unfortunately, the research in this area thus far is scarce. 
This paper aims to assess the feasibility of and strengths and weaknesses associated with 
using virtual reality simulations as a diagnostic tool to assess neurodegenerative 
conditions like MCI and dementia. It will involve a systematic look at preexisting 
literature and offer suggestions for future research based on its findings.  
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2  INTRODUCTION 
Neurological conditions like mild cognitive impairment (MCI) and dementia do not 
have a single method by which they are diagnosed. Oftentimes, doctors analyze a 
patient’s medical history, laboratory test results, characteristic changes in thinking, day-
to-day function and behavior. Computed tomography (CT) or magnetic resonance 
imaging (MRI) are also used to evaluate potential loss in brain mass which can point to 
cognitive changes or degeneration.  
In recent years, many clinicians have adopted virtual reality to treat and diagnose 
some health conditions; while this technology is more popular among mental health 
practitioners who use it to employ exposure therapy, sure enough, it is also slowly being 
adopted by neurologists and other specialists who specialize in cognitive functions. 
Neurodegenerative disorders like dementia and MCI affect a person’s ability to engage in 
daily activities, as a result, a careful analysis of how well patients engage in instrumental 
activities of daily living (IADL) can be used to assess cognitive condition (García-
Betances et al. 2015). These tests can be conducted through a physical test mockup in a 
hospital, but instead are often conducted via subjective surveys and tests given the 
constraint of space. Assessing IADL is easier to conduct using VR because it is more 
inexpensive than a physical mockup, it does not require the presence of a testing site, it is 
not invasive and it gives more precise data regarding the patient’s eye movements, which 
can be used to assess their ‘attention.’ Typically, these VR scenarios involve the patient 
to undertake a task they would do at any given day, such as making a pot of coffee or
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navigate through a supermarket. The clinician, who is able to see how the patient 
interacts with the environment through their device, can analyze the patient’s memory, 
general motor skills, balance, reflexes etc. This can enable them to gain a holistic 
understanding of the patient’s objective cognitive condition and enable them to provide a 
diagnosis or to rule it out. The use of VR to detect MCI and dementia is newly budding 
and while there is evidence that it is an effective method, there is a lot of room for 
improvement. The adoption of this form of technology can enhance the diagnosis process 
and allow patients to receive their diagnosis earlier and therefore take interventions to 
slow the progression of their condition.  
 
 
3 LITERATURE REVIEW 
Dementia is characterized by progressive decline in two or more cognitive domains, 
including memory, language, executive and visuospatial function, personality, and 
behavior, all of which affect one’s ability to efficiently engage in instrumental and/or 
basic activities of daily living (IADL) (Weller and Budson 2018). Symptoms of dementia 
are gradual, persistent and progressive (Duong et al. 2017). Individuals suffering from 
dementia experience changes in cognition and behavior which can and does affect their 
ability to function. Having a neurodegenerative condition can drastically affect a patient 
and his/her loved one’s lives. However, seeing behavioral changes that stem from said 
conditions and not having a definitive answer about their cause can be more troublesome. 
Oftentimes, patients live in this limbo in the early stages of their condition because there 
is no definitive physical way to diagnose these diseases in the early on. Behavioral 
changes that stem from cognitive changes are among the first symptoms (Bature et al. 
 5 
2017). Thus, many clinicians opt to test cognitive functions as a way to gain a better 
understanding of the patient’s cognitive condition. 
 
 
3.1 DEMENTIA, MILD COGNITIVE IMPAIRMENT & ALZHEIMER’S 
DISEASE 
 
Dementia presents itself uniquely in each individual; the cognitive deficits that 
stem from it can appear as memory loss, communication and language impairments, 
agnosia (inability to recognize objects), apraxia (inability to perform previously learned 
tasks) impaired navigation, and impaired executive function (reasoning, judgement and 
planning). Dementia is an umbrella term used to describe a clinical syndrome of 
progressive cognitive decline; the types of dementia are classified according to their 
cause. The 4 common types are: Alzheimer’s disease, vascular dementia, Lewy body 
dementia and frontotemporal dementia (Duong et. al. 2017). 
Cognitive impairment is a result of injury to the cerebral cortex caused by synaptic 
failure, inflammation and/or change in cerebral metabolism (Hildreth and Church 2015). 
Many individuals who suffer from mild deficits and do not meet the aforementioned 
criteria for dementia are considered to have mild cognitive impairment (MCI), which is 
defined to be an objective cognitive impairment with preserved function (Hildreth and 
Church 2015). Normal aging may bring about difficulties with language, memory, 
thinking or judgement; those with MCI may experience greater difficulty in these 
functions than those who experience normal aging. MCI can be assessed using cognitive 
testing and the impairments it presents are not sufficient to interfere with an individual’s 
daily activities (Petersen 2016). Alzheimer’s disease (AD), the most prevalent cause of 
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dementia, refers to a particular onset of functional and cognitive decline associated with 
age and a particular neuropathology (Soria Lopez et al. 2019). It is a progressive 
condition and individuals who suffer from it may present with MCI in the early stages 
(Matthews et al. 2008). Those who have been diagnosed with MCI are at a higher risk of 
developing AD and other dementias in comparison with those who do not have AD 
(Bruscoli and Lovestone 2004). MCI and mild dementia are both characterized by 
objective evidence of cognitive impairment. The main distinction between them is that in 
the latter, more than one cognitive function is impaired and there is substantial 
interference with daily life (Knopman and Petersen 2014). 
 
 
3.2 DIAGNOSING DEMENTIA & MCI  
 
The definitive diagnosis of dementia requires post-mortem evaluation of brain tissue  
(Weller and Budson 2018). Nonetheless, clinicians use a combination of tests to establish 
a high likelihood of the presence of a neurodegenerative disease like mild-cognitive 
impairment and dementia. The diagnosis is confirmed when the patient’s condition 
declines. These tests include cognitive and neuropsychological testing, laboratory tests, 
brain scans, psychiatric evaluations, and genetic testing. Some clinicians opt to use 
laboratory testing, computed tomography (CT) or magnetic resonance imaging (MRI) to 
evaluate potential loss in brain mass which can point to cognitive changes or 
degeneration (Jack et al. 2011) and to look for evidence of strokes from vascular 
dementia (Strub 2013). However, this method does not always yield accurate results, 
especially in the early stages of the disease when tissue loss is sparse. Instead, behavioral 
changes are among the first noticeable symptoms of dementia (Bature et al. 2017). 
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Neurodegenerative diseases affect an individual’s balance, speech, memory, gait, reflexes 
etc. which in turn affect their ability to complete daily tasks. Many of the aforementioned 
tests are designed to test the patient’s ability to engage in daily activities. Most clinicians 
do not face issues conducting psychiatric evaluations and interviewing the patient’s 
families about their condition, instead, the larger problem lies in testing the patient’s 
competency in engaging in instrumental activities of daily activities (IADL). Most 
activities designed to test cognitive function require the patient to complete some sort of 
task they would engage in on any given day (i.e. driving, cooking, wayfinding etc.) 
(Garcia-Betances et. al. 2015). Although it may seem simple, neurodegenerative diseases 
affect an individual’s balance, speech, memory, gait, reflexes etc. and a simple task can 
yield volumes of data about his/her cognitive function. Additionally, clinicians take a 
holistic look at the data they obtain from all of the tests conducted. Ideally, every 
healthcare setting should have a testing space in which the clinician can set up tasks for 
the patient to complete; however, this is not always the case. Real estate space in 
hospitals is very valuable and it is not realistic to expect all healthcare institutions to have 
the space and means to constantly set up and dismantle props for each physical testing 
scenario. Transdisciplinary research in neurology and virtual reality (VR) has fostered the 
development of ecologically valid virtual tools for the assessment of IADL, using 
simulations of real life activities in VR (Allain et al. 2014). Virtual reality testing is an 
inexpensive form of technology that is being adopted by many healthcare settings. 
Although VR was readily adopted by practitioners in the mental health field, it is also 
newly being explored as an affordable tool for the detection and treatment of 
neurodegenerative diseases. García-Betances et al. 2015 briefly summarized the role of 
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VR technology in relation to Alzheimer’s disease. They categorize VR use according to 
their intended purpose: diagnosis, patient cognitive training, caregivers’ education etc.; 
focus feature: spatial impairment, memory deficit, etc.; methodology employed: tasks, 
games etc.; immersion level, and passive or active interaction (García-Betances et al. 
2015). The diagram below delineates the categorization of current VR research as it 




Figure 1: A Map of VR technology use in relation to Alzheimer’s Disease 
 (García-Betances et al. 2015) 
 
 
Using VR as an assessment and diagnostic tool for cognitive condition has been 
explored by few studies. This paper is intended to delve into the recent publications 
exploring VR tools for the assessment and diagnosis for dementia and MCI. It will 
expand upon the technology used, the cognitive features tested, the side effects and the 





This systematic review was conducted based on guidelines belonging to the 
Cochrane Handbook for Systematic Review of Interventions and UNC’s Health Science 
Library Systematic Review resources.  
 
4.1 SEARCH STRATEGY 
 
Given that VR technology is a new field, some background research was initially 
conducted regarding the intersection of virtual reality technology and the treatment of 
cognitive impairments. It was discovered that the functions that AR/VR typically serve in 
this field are that of a (1) diagnostic and assessment tool, (2) cognitive training tool, and 
(3) empathy training tool for caregivers of those who are cognitively impaired. Many 
papers were found to focus on the latter two and the former was thus chosen as the area 
of focus.  
The goal of this systematic review, therefore, was to answer the following research 
questions: to explore how VR technology is being utilized to detect MCI and dementia, to 
explore the validity of using VR in this manner, and to unveil any strengths and 
weaknesses it may have in comparison to other forms of cognitive diagnostic testing. 
This background research also inspired the decision to not limit the studies based on the 
immersion level of the VR technology that was used, given that this is a budding field 
and research with fully immersive VR is scarce.  
Nine databases such as PubMed, Scopus, and Web of Science were used to search 
for systematic reviews that fall under a similar category and SciWheel (formerly known 
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as F100) was used to screen through these publications and build a repertoire of search 
terms. A health sciences librarian was consulted to help create a well-defined search 
strategy and build the search string to be used in the databases. See Table 1 below for 







PubMed 2/23/2020 180 #1: (virtual reality [mesh] or virtual reality [tw] 
or VRCT [tw] or head-up display [tw] OR head 
up display [tw] or head-mounted [tw] or head 
mounted [tw] or virtual environment [tw] or 
virtual environments [tw] or 3D environment 
[tw] or 3D environments [tw] or multi-sensorial 
interaction [tw] or virtual retinal display [tw]) 
#2: (Mild Cognitive Impairments [mesh] or 
mild cognitive [tw]or mild neurocognitive [tw] 
or dementia [mesh] or dementia [tw] or 
Alzheimer* [mesh] or Alzheimer* [tw]) 
#1 AND #2 
Scopus 2/23/2020 527 ( (TITLE-ABS-KEY ( "virtual reality" ) OR 
TITLE-ABS-KEY ( "VRCT" ) OR TITLE-
ABS-KEY ( "head-up display" ) OR TITLE-
ABS-KEY ( "head up display" )OR TITLE-
ABS-KEY ( "head-mounted" ) OR TITLE-
ABS-KEY ( "head mounted" ) OR TITLE-
ABS-KEY ( "virtual environment" ) OR 
TITLE-ABS-KEY ( "virtual environments" ) 
OR TITLE-ABS-KEY ( "3D environments" ) 
OR TITLE-ABS-KEY ( "3D environment" ) 
OR TITLE-ABS-KEY ( "multi-sensorial 
interaction" ) OR TITLE-ABS-KEY ( "virtual 
retinal display" ) ) ) AND ( ( TITLE-ABS-KEY 
( "mild cognitive" ) OR TITLE-ABS-KEY ( 
"mild neurocognitive" ) OR TITLE-ABS-KEY 
( "dementia" ) OR TITLE-ABS-KEY ( 
"Alzheimer*" ) ) )  
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WoS 2/23/2020 267 ((TS=("virtual reality" OR "virtual reality" OR 
VRCT OR "head-up display" OR "head up 
display" OR head-mounted OR "head 
mounted" OR "virtual environment" OR 
"virtual environments" OR "3D environment" 
OR "3D environments" OR "multi-sensorial 
interaction" OR "virtual retinal display")) AND 
(TS=("Mild Cognitive Impairments" OR "mild 
cognitive" OR "mild neurocognitive" OR 
dementia OR dementia OR Alzheimer* OR 
Alzheimer*))) AND LANGUAGE: (English) 
AND DOCUMENT TYPES: (Article) 
CINHAL 2/24/2020 60 AB (mild cognitive impairment or mci or 
Alzheimer or dementia ) AND AB ( virtual 
reality OR VRCT OR head up display OR 
head-up display OR head-mounted OR head 
mounted OR hmd OR virtual environment OR 
virtual environments OR 3D environment OR 
3D environments OR multi-sensorial 
interaction OR virtual retinal display) Narrow 
by Language: - english 
PsyINFO 2/24/2020 97 AB (mild cognitive impairment or mci or 
Alzheimer or dementia ) AND AB ( virtual 
reality OR VRCT OR head up display OR 
head-up display OR head-mounted OR head 
mounted OR hmd OR virtual environment OR 
virtual environments OR 3D environment OR 
3D environments OR multi-sensorial 
interaction OR virtual retinal display) Narrow 
by Language: - english 
ACM DL 2/24/2020 20 [[Abstract: "virtual reality"] OR [Abstract: 
"vrct"] OR [Abstract: "head-up display"] OR 
[Abstract: "head up display"] OR [Abstract: 
"head-mounted"] OR [Abstract: "head 
mounted"] OR [Abstract: "virtual 
environment"] OR [Abstract: "virtual 
environments"] OR [Abstract: "3d 
environments"] OR [Abstract: "3d 
environment"] OR [Abstract: "multi-sensorial 
interaction"] OR [Abstract: "virtual retinal 
display"]] AND [[Abstract: "mild cognitive"] 
OR [Abstract: "mild neurocognitive"] OR 
[Abstract: "dementia"] OR [Abstract: 
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"alzheimer*"]] 
Embase 2/24/20 264 ('virtual reality':ti,ab,kw OR vrct:ti,ab,kw OR 
'head-up display':ti,ab,kw OR 'head up 
display':ti,ab,kw OR 'head mounted':ti,ab,kw 
OR 'virtual environment':ti,ab,kw OR 'virtual 
environments':ti,ab,kw OR '3d 
environments':ti,ab,kw OR '3d 
environment':ti,ab,kw OR 'multi-sensorial 
interaction':ti,ab,kw OR 'virtual retinal 
display':ti,ab,kw) AND ('mild 
cognitive':ti,ab,kw OR 'mild 
neurocognitive':ti,ab,kw OR dementia:ti,ab,kw 
OR alzheimer*:ti,ab,kw) 
CochraneLibrary 2/24/2020 52+3 ((( "virtual reality" ) OR ( "VRCT" ) OR ( 
"head-up display" ) OR ( "head up display" 
)OR ( "head-mounted" ) OR ( "head mounted" ) 
OR ( "virtual environment" ) OR ( "virtual 
environments" ) OR ( "3D environments" ) OR 
( "3D environment" ) OR ( "multi-sensorial 
interaction" ) OR ( "virtual retinal display" ) ) ) 
AND ( ( ( "mild cognitive" ) OR ( "mild 
neurocognitive" ) OR ( "dementia" ) OR ( 
"Alzheimer*" ) ) ) in Title Abstract Keyword 
  
 




4.2 INCLUSION & EXCLUSION CRITERIA 
 
The following principles were drafted as inclusion criteria: (1) VR studies wherein 
VR is used as a diagnostic/assessment tool to screen for MCI/dementia; (2) studies that 
explore dementia or MCI detection must include a healthy control group opposite the VR 
diagnostic group, for results to be compared; (3) studies must compare the index test to a 
reference standard to ensure validity of results. The following were drafted as the 
exclusion criteria: (1) Studies conducted on individuals with multiple neurocognitive 
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disorders (NCDs); (2) studies conducted on patients who have dementia triggered by 
traumatic brain injury. (3) studies exploring VR as a tool for employing computerized 
cognitive therapy on individuals with dementia and MCI; (4) studies that use VR 





A total of 1421 paper titles and abstracts were uploaded to Covidence which was 
utilized for the remainder of the systematic review. Covidence, a tool that is free for UNC 
Chapel Hill affiliates, streamlines the process of building a repertoire of relevant citations 
and screening through them. As such, it is typically used by researchers who are 
conducting systematic reviews. Two researchers separately conducted a title and abstract 
screening and full text screening based on the inclusion and exclusion criteria. The 
Cohen's Kappa was 0.33577 and 0.46712 for the title and abstract review and the full-text 
review, respectively.  Disagreements and differences were resolved through discussion 
and a consensus was achieved at the end. While Covidence generally identifies and 
removes duplicate studies, it does not have robust artificial intelligence capabilities that 
yield a 100% success rate. Therefore, the deduplication process was manually conducted 
a second time following the full text review. In this step, many articles were removed due 
to language, incorrect or insufficient reference standards, and incorrect target groups. See 







Figure 2: PRISMA diagram for paper screening 
 
The two researchers then independently appraised the papers and disagreements 
were resolved among them. The quality assessment template was designed according to 
guidelines for diagnostic test studies as described in QUADAS-2  and Critical Appraisal 
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Skills Programme (CASP) (Whiting et al. 2006).1 The template included 6 questions that 
attempted to shed light on potential outcome reporting bias, review bias, and verification 
bias. It also included questions about whether the studies included a reference standard 
and information about the target group. Each question was checked as yes, no, or unsure 
by the researchers and the results were aggregated into an Excel sheet.  
 
 
5 DATA EXTRACTION & ANALYSIS 
For the remaining studies, data was extracted independently by the two researchers 
through a Google Forms survey and were then compared for accuracy. The survey 
consisted of 4 parts: identification, participant information, index standard information 
and outcomes. Identification asked questions about the title, authors, setting, country of 
testing site. The second section asked about the size, gender composition and age range 
of the healthy controls and the target groups. Section 3 dealt with matters such as the 
name, immersion level, description, and methodologies of the index test and the focus 
features that were tested. Section four asked about what the outcomes were, how they 
were measured, if they were favorable and what the limitations were.   
After the two researchers’ results were compared, the data was compiled into a single 
spreadsheet and color coded based on focus feature and immersion level.  See appendix 3 
for data extraction template.  
 
 
                                                
1 “CASP Checklist: 12 Questionsto Help You Make Sense of a Diagnostic Test Study.” 





Of the 34 studies, 12 focused on assessing MCI alone, 8 focused on Alzheimer’s 
disease only, and only 1 concentrated on those with general dementia. The remaining 
studies tested several target groups with two or three of the conditions listed above. After 
analyzing their results, all of the authors considered their tool to be a valid testing tool for 
diagnosing MCI and/or dementia (depending on the condition they tested). Although it 
cannot be said that there is a direct and complete match between the index test and the 
reference test results, all studies reported a very high correlation between the two results. 
One study even conducted a virtual hospital navigation tool in real life and via simulation 
(Cushman et al. 2008). The virtual hospital was designed to be identical to the real one 
for increased validity and the authors reported that participant performance revealed 
similar profiles of impairment in real-world and virtual testing across all groups.  
The most commonly used reference test was the Mini Mental Status Examination 
(MMSE), however, most of the papers utilized a few reference tests including a battery of 
neuropsychological testing, interviewing,  and other paper and pencil tests such as 
Functional Activities Questionnaire, Geriatric Depression Scale (GDS), Clinical 
Dementia Rating Scale (CDR). One paper used CSF biomarkers as one of the reference 
standards (Allison et al. 2016). The studies were conducted in various countries including 
but not limited to the USA, South Korea, France, Turkey, Spain and Greece. While there 
was no specific age range listed in the inclusion and exclusion criteria, the papers were 
required to test ‘elderly participants.’ The age range that was tested across all papers 
ranged from 50 to 90. A few of them even tested a younger age group in addition to a 
control and target elderly group for more robust age and health data (Zakzanis et al. 
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2009) (Sauzéon et al. 2016). Varying results were noted regarding the outcomes linked to 
demographics (age, gender, education level, computer literacy etc.). Most of the studies 
indicated that there was no correlation between performance and demographic data, while 
some indicated that age had the highest correlation with performance, although it was not 
very significant (Pengas et al. 2010); (Kim et al. 2018); (Zakzanis et al. 2009). One study 
indicated that there might be a small correlation between high performance and education 
level, but it highlighted that age was more strongly correlated (Baez et al. 2015). All of 
the studies emphasized a strong correlation between cognitive health and index and 
reference test performance. See table 2 below for study characteristics.  
 
 









      
      
 
 
-  = the VR systems where not given specific names  
 
 





Although the majority of these tests can theoretically be conducted in real life, the 
biggest strengths of VR testing is that it offers increased accessibility for disabled and 
elderly patients. In addition, VR environments can promote ‘presence,’ or the feeling of 
truly being in a real-world situation, instead of a simple VR environment. The system’s 
depth of immersion and level of fidelity determine the level of presence experienced by 
the user. Slater et al. (2009) use the term ‘fidelity’ to describe the degree to which a 
system stimulates replicates real-world sensory experience (Slater et al. 2009). Immersion 
level is determined based on ‘(i) number of stimulated senses, (ii) quantity and level of 
interactions, (iii) synthetic stimuli fidelity, and (iv) system’s ability to isolate the user 
from external stimuli’ (García-Betances et al. 2015). VR simulations can be categorized 
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roughly into 3 groups: fully immersive, semi-immersive, and non-immersive. Non-
immersive immersive systems involve the use of a typical workstation including a 
desktop monitor with conventional graphics, a keyboard, mouse and/or joystick. A fully 
immersive system involves the use of 3D displays such as head-mounted displays 
(HMD), 3-4 surrounding projection surfaces and either a glove or another form of a high 
capacity input device (Costello 1997). Tarnasas et al. 2013 used a unique example of a 
fully immersive setup: it involved a curved rear projection screen and a split belt 
treadmill with force plates (Tarnanas et al. 2013). 
 
 
Figure 3: VR-DOT, a fully immersive VR system (Tarnanas et al. 2013). 
 
Semi-immersive environments fall in between the two; they typically use a 
system with slightly more sophisticated graphics along with either a larger screen 
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monitor, large screen projector, and/or multiple projection systems.  They also involve 
the use of a keypad and mouse or joystick. The higher the immersion level of a system, 
the higher the fidelity and the feeling of ‘presence.’ HMDs usually provide the highest 
level of immersion. 
According to Ma and Zheng 2011, the two most crucial features of a VR system 
are (i) the users’ ability to control their movement in the virtual environment and (ii) the 
users’ ability to interact with objects or interfaces in the environment through the use of 
an input device. These devices can be a mouse, gamepad, joystick, glove etc.; they are 
chosen based on the immersion level of the system. One characteristic they have in 
common is they provide responses (i.e. signals, haptic feedback etc.) from the system to 
the user when the user engages with the environment (Ma and Zheng 2011). The more 
immersive the system, the more complex the input device is.  
While more immersive devices have the ability to increase ‘presence,’ they can also 
lead to side effects such as cyber sickness or visually induced motion sickness (VIMS) 
either during or after the test. Garcia-Betances et al. 2015 refer to the term ‘virtual reality 
induced sickness symptoms and effects’ (VRISE), which emphasizes that this VR 
induced motion sickness is correlated to the immersion level of the device. Typically, 
more immersive devices can yield higher VRISE rates (García-Betances et al. 2015). 
 
6.2 INTERACTION TECHNIQUES 
 
VE methodologies and modalities varied across the studies; nonetheless, they all 
focused on a task, activity or game. García-Betances et al. 2015 define tasks as particular 
actions that are intended, designed, and utilized to test a specific cognitive function; 
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activities encompass performing high-level sustained cognitive actions and processes 
such as: eating, cooking, shopping, etc.; and games refer to activities that are defined by 
rules and user engagement (García-Betances et al. 2015). Moreover, they specifically 
define some VE activities as IADL tasks that test aptitude for activities that are engaged 
in on a daily basis. Many of the studies that tested spatial navigation and orientation 
involved tasks, which focused on navigating through an environment or a maze and 
locating objects. Those that tested executive function and general memory typically 
involved an activity- particularly an IADL activity. These categories are not absolute, in 
fact the lines between them can be fuzzy depending on the simulation. For example, 
Tarnanas et al. 2014 created a fire evacuation simulation where participants are required 
to follow the rules to exit a building that has caught fire (Tarnanas et al. 2014). Given the 
abundance of rules, this would be considered a game, but it can also arguably be an IADL 
activity as it simulates a real-life situation.  
 
 
6.3 FOCUS FEATURES 
 
Persons with dementia (PWDs) experience a variety of symptoms stemming from 
cognitive impairment; many of the papers chose to test either those that are most 
widespread or those that appear earliest in individuals with cognitive decline. The main 
focus features that were tested across the papers were attention, general memory, 
orientation, and kinematic irregularities. For the purposes of comprehension, the focal 
aspects can be further summarized as follows: (1) Attention (i.e. ability following 
directions, focus), (2) executive functions (cognitive functions that are needed to 
accomplish complicated tasks), (3) general memory (i.e. non-verbal episodic, allocentric, 
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egocentric, temporal order memory, prospective, short-term, working memory, 
associative memory), (4) orientation (i.e. allothetic, visuospatial, wayfinding, spatial 
navigation, topographical disorientation, spatial memory, route recall), (4) kinematic 
behavior (i.e. motor skills).  
The brain is very complex and different regions dictate certain behaviors and 
cognitive functions. Similarly, given that many of these features and their sub-features 
work hand in hand, there is no definitive way to categorize them. For example, a system 
that is designed to test a patient’s orientation ability may rely on testing other features 
such as egocentric and/or allocentric memory as well as attention and spatial memory. 
Some tests, like the one developed by Zakzanis et al. 2009, are even designed to test 
multiple focus features at a time for more robust and accurate assessment (Zakzanis et al. 
2009). It is imperative to note that almost two-thirds of the papers focused mainly on 
orientation and/or orientation along with another focal aspect. This may be because it is 
one of the first forms of impairments experienced by those with dementia; spatial 
navigation performance can even predict pre-dementia syndromes in aging (Verghese et 
al. 2017).  
 
6.3.1 ORIENTATION & SPATIAL MEMORY  
 
As mentioned above, most of the studies tested orientation and spatial memory. 
Studies that fall into this category are designed to test sub focus features such as: 
egocentric memory, allocentric memory, wayfinding, visuospatial memory, and route 
learning ability.  
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Wayfinding and navigation are the main sub-features that are used to test 
orientation. Typically, wayfinding is tested by allowing the participants to navigate freely 
through an environment while paying attention to salient landmarks in their environment. 
They are then asked to recall some of the objects they saw. Allison et al. 2016 asked 
participants to recall as many landmarks as they could remember and then locate them on 
a 2D map of the environment. They also tested the participants’ route learning ability by 
asking them to replicate the route they followed on a 2D map (Allison et al. 2016). 
Shamsuddin et al. 2012 also tested route learning ability, but asked the participants to 
replicate a pre-learned route in the VE (Shamsuddin et al. 2012). Unlike the previous 
study, this one did not comment on whether the skill could be transferred from a 3D to a 
2D environment. 
Wayfinding and navigation are also tested by first giving directions to the location 
of the objects and testing whether the participants are able to find them in the VE. 
Tarnasas et al. 2012 designed a test wherein the participants were asked to roam around a 
virtual museum and become familiar with its layout; the participants were then given 
pictures of 5 archeological artifacts and directions on how to locate them. They were 
given a few minutes to try and memorize the pictures and directions and then asked to 
locate the objects (Tarnanas et al. 2012). This test was designed to characterize cognitive 
profiles in an ecological fashion, which involves analyzing memory as it relates to central 
and perceptual details. Allison et al. 2016 followed a similar test design in which they 
indicated a landmark in a VE; their approach differed in that they encouraged their 
participants to find the shortest distance to the landmark from their current location 
(Allison et al. 2016). 
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Pengas et a. 2010 and Shamsuddin et al. 2012 attempted to test topographical 
memory by assessing participants’ wayfinding ability, visuospatial ability and ability to 
follow directions. Topographical memory is characterized as the ability to recall the 
design, shape, or structure of a previously experienced environment or landmark. In the 
former study, participants were asked to follow a set of directions to find a landmark in a 
VE; once familiar with the environment they were asked to find another landmark by 
using visual cues. Once at the landmark they were asked to delineate its direction 
respective to themselves by using cardinal egocentric pointers (ahead, behind, to the left, 
or to the right) (Pengas et al. 2010) (Shamsuddin et al. 2012).  
Lee et al. 2014 attempted to assess spatial working memory, which refers to short-
term memory that is concerned with immediate conscious perceptual and linguistic 
processing. They designed a maze consisting of one room with 6 identical hallways 
attached to it forming an asterisk shape. The participants were asked to find various 
objects located in these hallways and their working memory was tested based on how 
frequently they entered the same incorrect hallways and doors (Lee et al. 2014).  
Sauzeon et al. 2016 devised a very comprehensive test which examined 
participants’ orientation, attention, free recall and episodic memory, which is “the ability 
to learn, store, and retrieve information about unique personal experiences that occur in 
daily life” (Dickerson and Eichenbaum 2010). A route was demonstrated in a virtual 
hospital; the participants were tested on their ability to (1) recall the route and (2) recall 
relevant objects. With regards to the former, subjects were asked to recall the route from 
an egocentric perspective, they were asked to replicate it on a 2D map, and when shown a 
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series of objects that they saw in the virtual hospital, they were asked to ‘point in the 
direction of the location depicted as if there were no 
walls between themselves and the object’ (Sauzéon et al. 2016). With regards to the 
second portion, participants were asked to list the objects they saw in the environment, 
recall the salient landmark objects, and determine where they saw each object.  
In a similar fashion, Cushman et al 2008 also designed their test in such a way 
where the computer passively led the participant through a virtual house. Their test was 
intended to examine executive functioning (EF) and episodic memory. Objects were 
placed in certain locations around the virtual house and subjects were asked to be 
attentive throughout the exploration process. They were then asked to complete a free-
recall of the objects Cushman et al. 2008). 
 
 
6.3.2 EGOCENTRIC & ALLOCENTRIC MEMORY 
 
Allocentric or ‘world-centered’ navigation, refers to utilizing environmental 
features (i.e. buildings, monuments) external to the self, in order to navigate through a 
place. Egocentric navigation refers to the mental understanding of the route being 
travelled including direction, the distance that has been travelled, the time that has passed 
etc.  (Weniger et al. 2011). Serino et al. 2015 compared the results of two tests that 
focused on ego and allocentric memory. They asked participants to indicate the position 
on a map of an object they had seen in a room in real life (allocentric memory); they were 
then asked to retrieve the position from an empty version of the same virtual room, 
starting from a different position (egocentric) (Serino et al. 2015);  
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Weniger et al. 2015 and Mohammadi et. al. 2018 asked participants to participate 
in a virtual park and neighborhood navigation task, respectively, to test allocentric 
memory. They then asked participants to participate in a virtual maze wayfinding task to 
test egocentric memory. The results were compared and it was found that those who 
suffer from MCI and dementia performed relatively worse than healthy control in both 
these features (Weniger et al. 2011) (Mohammadi et al. 2018). Mohammadi et al. 2018 
also indicated that performance on the maze was significantly worse than the 
neighborhood navigation task amongst the test group.  
Tu et al. 2017 chose to test these two features through the employment of a virtual 
supermarket task, in which participants were asked to find specific items from a shopping 
list. Initially the participants navigated through the market in first person (egocentric 
navigation); after maneuvering for a bit they were then asked to locate their current 
location on a map of the supermarket (allocentric memory) and were checked for 
accuracy  (Tu et al. 2017). 
 
6.3.3 EXECUTIVE FUNCTIONS & GENERAL MEMORY  
 
Executive functions are complex cognitive functions that are needed to 
accomplish complicated tasks. Executive function disorders include “attention deficit, 
planning, problem-solving, multi-task, monitoring and behavior control”(Yeh et al. 
2012). Many of the studies tested executive function alongside orientation and general 
memory. These tests typically involved IADL tasks and they tested several cognitive 
elements that would be affected in patients with MCI or dementia.  
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One of the most popular IADL tasks in this category is the virtual supermarket 
(VSM). While Eraslan Boz et al. 2020, Zygouris et al. 2015, Werner et al. 2009, Yeh et 
al. 2012 and Yeh et al. 2012 all used some form of a VSM, the focus features they tested 
were not identical.  Most VSM studies ask participants to find and purchase specific 
items from the VSM. They are often judged based on whether they bought the correct 
product types and quantities, if they bought anything they were not supposed to and 
whether or not they conducted the financial transaction accurately (Eraslan Boz et al. 
2020) (Zygouris et al. 2015) (Yeh et al. 2012). Because this is also a navigation task, the 
VSM also tests visual and verbal memory, executive functions, attention, and spatial 
navigation.  
Some studies chose to test cognitive function by focusing mainly on the 
participants’ general memory (comprising of verbal, visual, and episodic and associative 
memory). One study in particular asked participants to watch a short clip that simulated a 
real-life social event (i.e. a scene from a birthday party where the guests casually chat 
about their lives).  They were then asked to recall the seating arrangement, information 
about a randomly chosen guest (name, relationship to host, city of residence, occupation, 
hobby etc.) and match the name of the guests to a picture of their face (Kim et al. 2018). 
Associative memory, the ability to learn and remember the relationship between 
unrelated item, is another sub focus feature that is tested under general memory. 
Montenegro and Argyriou 2015 designed a simulation in which participants were asked 
to memorize a list of objects and locate them in a simulation; they were then show object 
pairs, asked to memorize their interaction and then accurately indicate the pairs and their 
functions (Montenegro and Argyriou 2015). The key feature of this test is that the objects 
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displayed are everyday objects the subjects might interact with in real life and the 
interaction feature was chosen at random. In other words, the object pairs did not follow a 
pattern (i.e. teacup and saucer, plate and fork etc.); otherwise the purpose of testing 
associative memory would be defeated.  
 
 
6.3.4 KINEMATIC BEHAVIOR  
 
Among the studies analyzed, kinematic movement analysis was not a popular 
assessment method for MCI and dementia. However, unlike questionnaires and computer 
based tests, they can yield complex, objective performance data. Seo et al. 2017 asked 
their participants to complete two tasks: (1) withdraw money from the bank and (2) take a 
bus to a specific location. Because the test was fully immersive, they were able to see a 
great deal of body movement. As the participants interacted with the environment, eight 
motion tracking cameras collected the position of both their dominant hand and head 
movement. Not only were the participants assessed based on the accuracy of the tasks 
they completed, but the cameras yielded extra information about their head trajectory: 
total distance of head movement during the task, their time to completion, and head 
speed: mean velocity of the head while taking a bus. Interestingly, in this study neither of 
the two kinematic measures (hand and head speed) correlated with the results on the 
neuropsychological testing. They did, however, uniquely discriminate between MCI and 
healthy controls (Seo et al. 2017). 
The study that tested the most comprehensive list of focus features tested the 
efficacy of VR-DOT, a module that requires multitasking in a fire evacuation drill 
setting, in detecting MCI. Not only did they collect behavioral data to compute EF, 
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orientation, and memory, but they also used LEAP motion and Microsoft Kinect camera 
sensors inside the headset to collect quantitative kinematic behavior like grip strength and 





There are few limitations in the current study. The first is that due to the 
heterogeneity regarding the test location, there was no standard language that was used in 
the testing portion of the studies. While this may not seem like a critical issue, languages 
have different semantic rules and users may react differently with systems based on the 
wording or phrasing of some of the rules they are provided. A second limitation was that 
there was a wide range of focus features tested and devices used. As a result, the authors 
collected different types of data using different measures that cannot be quantitatively 
compared across studies. Future research should target papers with similar task designs 
and focus features for comparable robust quantitative results. A few of the articles were 
eliminated from the quantitative analysis because they were not open access and could 
not be located even with help from an HSL librarian. Finally, the biggest limitation of 
this study was the scarcity of research in this field; as the field grows, reviews of this 





This study used the systematic review method was undertaken to screen through  
literature that used virtual reality technology to assess cognitive condition and provide 
diagnosis for MCI, dementia or Alzheimer’s disease.  The standard battery of testing that 
is used to detect MCI, dementia, and Alzheimer’s is not perfect. It can be invasive, yield 
subjective data about the patient from their loved ones, and often times is not efficient in 
forming early prognoses. VR is an effective alternative to physical cognitive testing that 
can offer objective data regarding a patients’ cognitive condition. The studies examined 
in this review were modeled according to tasks or activities that would easily indicate 
areas of cognitive decline in the brain. Many of the authors emphasized that specific 
cognitive dysfunctions like spatial impairment can be one of the first forms of 
impairments experienced by those with dementia (Verghese et al. 2017). These 
impairments can sometimes be missed by loved ones of MCI and dementia patients, but a 
physical test can easily discriminate a healthy control from an individual who suffers 
from MCI or dementia.  VR assessment tests are low-cost, computerized, and a 
noninvasive way to assess for cognitive condition. They also provide eye tracking 
capabilities which can provide valuable insight into a patient’s memory, attention, and 
gaze- all parameters that are used to assess dementia (Davis and Sikorskii 2020). Given 
that the research in this area is still very new, there is a lot of room for improvement. 
Future research should focus on targeting more and multiple focus features, increased 
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Key Terms: 
 
#1 AND (#2 OR #3) 
 
#1: (virtual reality [mesh] or virtual reality [tw] or VRCT [tw] or head-up 
display [tw] or head-mounted [tw] or head mounted [tw] or virtual environment 
[tw] or virtual environments [tw] or 3D environment [tw] or 3D environments 
[tw] or multi-sensorial interaction [tw] or virtual retinal display [tw]) 
#2: (Mild Cognitive Impairments [mesh] or mild cognitive [tw]or mild 
neurocognitive [tw] or dementia [mesh] or dementia [tw] or Alzheimer* [mesh] 
or Alzheimer* [tw]) 
 
(TS=("virtual reality" OR "virtual reality" OR VRCT OR "head-up display" 
OR head-mounted OR "head mounted" OR "virtual environment" OR "virtual 
environments" OR "3D environment" OR "3D environments" OR "multi-
sensorial interaction" OR "virtual retinal display")) AND ((TS=("Mild 
Cognitive Impairments" OR "mild cognitive" OR "mild neurocognitive" OR 
dementia OR dementia OR Alzheimer* OR Alzheimer*)) OR (TS=(Aging OR 




Table 3: Search Key terms & combinations used in database search 
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o Reference Standard: Expert clinical diagnosis, 
MRI scans, Biomarkers etc. anything that is 




• Verification Bias: Did all patients get the same 
diagnostic test and reference standard? 
o HINT: Consider •were both received regardless of 






• Review Bias: Could the results of the test have been 
influenced by the results of the reference standard? 
o HINT: Consider •was there blinding, 







• Is the disease status of the tested population clearly 
described? 
o HINT: Consider • presenting symptoms • disease 
stage of severity • co-morbidity • differential 






• Outcome reporting bias: Were all test results reported, 
including uninterpretable or intermediate test results? Did 
the authors mention not reporting some results? 
o Did they avoid the selective reporting of some 
outcomes but not others, depending on the nature 






Table 4: Qualitative Assessment Template. 
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Identification 
 
1. List the authors 
2. What is the title of the publication? 
3. What is the country of publication? 
4. Where was the test conducted? 
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5. What is the year of publication? 






1. What was the size of the control group?  
2. What is the age range of the control group?  
3. What is the gender composition of the control group?  
 
Target Group 
4. Which target groups were tested? Check all that apply. 
a. ‘MCI, AD, Dementia, Other’ were listed as options 
5. What was the size of the target group?  
6. What is the age range of the target group?  
7. What is the gender composition of the target group?  





1. Were the target and control groups given the same reference and index standards? 
a. ‘Yes, No, Unsure’ were listed as options 
2. What was the name and acronym of the intervention? 
3. What was the duration of the intervention testing? Skip if not applicable. 
4. Which reference standards were used to test for cognitive ability? 
a. ‘MMSE, blood test, Neuroimaging, Neuropsychological testing, medical 
history, Laboratory testing, other’ were listed as options 
5. Which VR methodology(s) was used? 
a. ‘Task, IADL, Game,’ were listed as options 
6. Please describe the methodology(s) setup briefly. 
7. What measurements were taken (i.e. time on task, cursor movement etc.)? 
8. What was the immersion level? 
a. ‘Full, semi, none’ were listed as options 
9. Which focus feature(s) were tested? 
a. ‘Spatial Memory, Allothetic orientation, egocentric orientation, 
Navigation/wayfinding, Topographical disorientation, General memory 
functions, executive functions, Motor skills/ Psychomotor slowing, 
Strategic and critical thinking, other’ were listed as options 




1. What were the outcomes of the test? 
2. Outcome 1: How were the results of the index test measured? (i.e. unit of 
 35 
measurement if relevant etc. )  
3. Outcome 2: Is there a notable difference in outcome that the authors associated to 
age, gender, education level, computer literacy etc.? (If, yes, explain.) 
4. Outcome 1: According to the authors are these results favorable? 
a. ‘Yes, no’ were listed as options 
5. Did the authors highlight any future research that needs to be conducted to 
validated this test? (I.e. did they refer to these: from whom, what and when). Skip 
if irrelevant. 
6. What were some limitations? 
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